Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 169.7 USD 1.67% Market Closed
Market Cap: 10.3B USD

Intrinsic Value

The intrinsic value of one JAZZ stock under the Base Case scenario is 298.07 USD. Compared to the current market price of 169.7 USD, Jazz Pharmaceuticals PLC is Undervalued by 43%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JAZZ Intrinsic Value
298.07 USD
Undervaluation 43%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jazz Pharmaceuticals PLC

What is Valuation History?
Ask AI Assistant
What other research platforms think about JAZZ?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JAZZ valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Jazz Pharmaceuticals PLC.

Explain Valuation
Compare JAZZ to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about JAZZ?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jazz Pharmaceuticals PLC

Current Assets 3.8B
Cash & Short-Term Investments 2B
Receivables 764.4m
Other Current Assets 945.4m
Non-Current Assets 7.6B
PP&E 250.1m
Intangibles 6.4B
Other Non-Current Assets 957.3m
Current Liabilities 2.3B
Accounts Payable 152.2m
Accrued Liabilities 906.5m
Other Current Liabilities 1.2B
Non-Current Liabilities 5.1B
Long-Term Debt 4.3B
Other Non-Current Liabilities 791.4m
Efficiency

Free Cash Flow Analysis
Jazz Pharmaceuticals PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jazz Pharmaceuticals PLC

Revenue
4.2B USD
Cost of Revenue
-478.5m USD
Gross Profit
3.7B USD
Operating Expenses
-3.2B USD
Operating Income
453.9m USD
Other Expenses
-822.3m USD
Net Income
-368.5m USD
Fundamental Scores

JAZZ Profitability Score
Profitability Due Diligence

Jazz Pharmaceuticals PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
ROIC is Increasing
Sustainable 3Y Average Operating Margin
45/100
Profitability
Score

Jazz Pharmaceuticals PLC's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

JAZZ Solvency Score
Solvency Due Diligence

Jazz Pharmaceuticals PLC's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Positive Net Debt
37/100
Solvency
Score

Jazz Pharmaceuticals PLC's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JAZZ Price Targets Summary
Jazz Pharmaceuticals PLC

Wall Street analysts forecast JAZZ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAZZ is 212.17 USD with a low forecast of 148.47 USD and a high forecast of 259.35 USD.

Lowest
Price Target
148.47 USD
13% Downside
Average
Price Target
212.17 USD
25% Upside
Highest
Price Target
259.35 USD
53% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Jazz Pharmaceuticals PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for JAZZ is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

JAZZ Insider Trading
Buy and sell transactions by insiders

JAZZ News

Other Videos
What is the Intrinsic Value of one JAZZ stock?

The intrinsic value of one JAZZ stock under the Base Case scenario is 298.07 USD.

Is JAZZ stock undervalued or overvalued?

Compared to the current market price of 169.7 USD, Jazz Pharmaceuticals PLC is Undervalued by 43%.

Back to Top